Related Experiment Videos
Adverse reactions to vancomycin prophylaxis in cardiac surgery
1University of Barcelona, Department of Anesthesiology, Hospital Clínic i Provincial, Spain.
Journal of Cardiothoracic and Vascular Anesthesia
|December 1, 1991
Summary
Vancomycin prophylaxis in cardiac surgery causes significant hypotension in over 25% of patients. This antibiotic poses a high, unpredictable risk of adverse reactions, particularly in cardiac surgical procedures.
Area of Science:
- Cardiology
- Pharmacology
- Infectious Diseases
Background:
- Vancomycin is frequently used for antibiotic prophylaxis in cardiac surgery.
- Adverse effects associated with vancomycin administration are a concern.
Purpose of the Study:
- To assess the incidence of adverse responses to vancomycin prophylaxis in cardiac surgical patients.
- To identify potential risk factors for vancomycin-induced adverse effects.
Main Methods:
- Prospective study of 116 cardiac surgical patients receiving vancomycin prophylaxis.
- Intravenous vancomycin administered over 30 minutes post-anesthetic induction.
- Control group of 10 patients monitored before vancomycin administration.
Main Results:
- 26.72% of patients experienced adverse effects, primarily hypotension (25%).
- Severe hypotension occurred in 12.93% of patients.
- Maculopapular erythema (Red-Man's syndrome) occurred in 6.03% of patients.
Conclusions:
- Perioperative vancomycin prophylaxis in cardiac surgery is associated with a high incidence of significant hypotension.
- The risk of adverse reactions appears unpredictable and not clearly related to patient demographics or surgical factors.